Saturday 17 October 2026
Export BPTSY’s income statement to Excel — free account
Biophytis SA Sponsored ADR
BPTSY Healthcare Biotechnology
Operating cash flow growth for three consecutive years.
0.25
0.00
0.00%
Follow BPTSY
| Jun '25 | Dec '24 | Jun '24 | Dec '23 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | 0.00% |
+8 more TTM periods Free account |
|
| 0.00% | 0.00% | 0.00% | 0.00% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(33.89) | (38.64) | (49.46) | (53.80) | |
Capital Expenditures |
— | 0.00 | (0.17) | 0.00 | |
| Other line items | |||||
Cash ROIC |
(2,259.62%) | (8,753.96%) | (829.06%) | (481.94%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | — | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Depreciation/Fixed assets |
13.65 | 2.41 | 8.97 | 2.66 | |
Capex/Depreciation |
0.00 | 0.00 | (0.06) | 0.00 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 |
Columns are period end dates